The coverage landscape was contracting rapidly, even as clinical evidence supporting GLP-1 use for weight management continued to strengthen
GLP-1 Drugs and Eating Disorders: A Hidden Risk in the Weight Loss Revolution By Donnisa Edmonds, C2ST Intern, University of Chicago In 2021, the FDA announced that they had approved Wegovy, a GLP-1 receptor agonist, as a treatment for chronic weight management
Many women navigating menopause wonder: can you take weight loss injections with HRT
Despite the benefits of weight reduction, there are many challenges in losing weight and maintaining long-term weight loss
The broader federal workplace drug testing program (applicable to federal employees and federal contractors under Executive Order 12564 and the Drug-Free Workplace Act) follows the same SAMHSA five-panel testing structure
Obesity doctors and researchers say within several years, they expect treatment will be more customized to meet the needs of each patient
